Genmab reported DKK523M in Loan Capital for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US USD 37.35B 193M
AstraZeneca AZN:LN USD 23.69B 9M
Bayer BAYN:GR EUR 33.79B 5.67B
Biomarin Pharmaceutical BMRN:US USD 1.08B 1.17M
Galapagos GLPG:NA EUR 14.69M 1.07M
Genmab GEN:DC DKK 523M 27M
GlaxoSmithKline GSK:LN GBP 17.04B 2.29B
GN Store Nord GN:DC DKK 10.13B 881M
Hikma Pharmaceutical HIK:LN USD 1.14B 279M
Insmed INSM:US USD 1.15B 347.41M
Lonza Group LONN:SW CHF 1.55B 393M
Merck MRK:GR EUR 9.2B 66M
Novartis NOVN:VX USD 21.78B 547M
Regeneron Pharmaceuticals REGN:US USD 2.7B 300K
Roche Holding ROG:VX 21.39B 978M
William Demant Holding WDH:DC DKK 7.86B 2.99B